Posttranscriptional regulation plays a fundamental role in the biology of embryonic stem 20 cells (ESCs). Many studies have demonstrated that multiple mRNAs are coregulated by 21 one or more RNA binding proteins (RBPs) that orchestrate the expression of these 22 molecules. A family of RBPs, known as PUF (Pumilio-FBF), is highly conserved among 23 species and has been associated with the undifferentiated and differentiated states of 24 different cell lines. In humans, two homologs of the PUF family have been found: 25 Pumilio 1 (PUM1) and Pumilio 2 (PUM2). To understand the role of these proteins in 26 human ESCs (hESCs), we first demonstrated the influence of the silencing of PUM1 and 27 PUM2 on pluripotency genes. OCT4 and NANOG mRNA levels decreased significantly 28 with the knockdown of Pumilio, suggesting that PUMILIO proteins play a role in the 29 maintenance of pluripotency in hESCs. Furthermore, we observed that the hESCs 30 silenced for PUM1 and 2 exhibited an improvement in efficiency of in vitro 31 cardiomyogenic differentiation. Using in silico analysis, we identified mRNA targets of 32 PUM1 and PUM2 expressed during cardiomyogenesis. With the reduction of PUM1 and 33 2, these target mRNAs would be active and could be involved in the progression of 34 cardiomyogenesis.
INTRODUCTION
Human embryonic stem cells (hESCs) are pluripotent cells derived from the 5 139 (34) were added to the cell culture in OptiMEM containing Lipofectamine 2000 for 4 140 hours. Then, the medium was replaced with supplemented DMEM, as described above. 141 After 48 and 72 hours, the medium was collected and centrifuged twice at 141000 x g. 142 The cell pellet was resuspended in 1X PBS and stored at -80 ºC. 143 For transduction, hESCs were cultured on 6-well plates and different dilutions of 144 the lentiviruses were tested (Supplementary Figure 2) , and the dilution was defined as 145 10 -3 for all experiments. After the transduction, the medium was replaced and hESCs 146 were cultured for 24 hours to induce cardiac differentiation. 147 148 RNA extraction and quantitative RT-qPCR 149 RNA was extracted using the RNeasy Kit (Qiagen), and the cDNA reaction was 150 performed using the Improm II Kit (Promega) according to the manufacturer's 151 instructions. Samples were obtained from three replicates for undifferentiated cells and 152 from three independent cardiac differentiations. Amplifications were carried out in a 153 final volume of 10 μl containing SYBR Select master mix (Applied Biosystems), 100 ng 154 cDNA template, and 5-10 pmol primers. The RT-qPCR conditions followed the 155 manufacture's recommendations (Applied Biosystems), using the LightCycler system 156 (Roche). The melting curves were acquired after RT-qPCR to confirm the specificity of 157 the amplified products ( Supplementary Table S1 ). We generated standard curves for 158 each gene, including the GAPDH (housekeeping) gene. Amplifications were performed 159 in triplicate. Cq results for each gene were normalized based on GAPDH expression and 160 the analysis of relative expression were performed.
162
Flow cytometry 163 During cardiac differentiation, the cells were immunophenotyped by flow 164 cytometry to confirm differentiation stages. The EBs were dissociated with 0.25% 165 trypsin/EDTA (5 min) and resuspended in PBS/0.5% BSA. On day 3, the cells were 166 incubated with anti-CD56 (BD) antibody (1:12.5) for 20 min at 4 ºC. On day 9, the cells 167 were only dissociated for eGFP detection. On day 15, for cTnT staining, the EBs were 168 incubated with trypsin/0.25% EDTA for 20 min, followed by inactivation with DMEM 169 supplemented with 50% SFB and DNase I (20-30 U/ml). After dissociation, the cells 170 were fixed with 4% formaldehyde (20 min), followed by permeabilization with 0.5% 171 Triton X-100 (25 min). Then, the cells were incubated with an anti-cTnT primary 6 172 antibody (Thermo Fisher Scientific) (1:100) for 30 min at room temperature, followed 173 by incubation with Alexa Fluor 633 secondary antibody (1:1000) (30 min). The cells 174 were analyzed on a FACSCanto II (BD) flow cytometer. Data analysis was performed 175 using FlowJo software (v.10).
177
Immunofluorescence 178
The immunofluorescence protocol followed as previously described (7). Briefly, 179 monolayer cultures we fixed with paraformaldehyde 4%, rinsed with PBS, followed by 180 incubation with blocking buffer (PSA/BSA 5%) for 60 min. Then, cells were incubated 181 with primary antibodies for Pumilio 1 (1:300, Bethyl laboratories Inc.), Pumilio 2 (1:70,
182
Bethyl laboratories Inc.) or OCT4 (1:100, Abcam), diluted in blocking buffer, for 60 183 min, at 30°C. After three PBS washes, cells were incubated with Alexa Fluor® 488 anti-184 goat or anti-rabbit secondary antibody, for 60 min, at 30°C. DAPI were staining for 10 To understand the role of PUM1 and PUM2 in hESC maintenance or during 236 cardiomyogenic differentiation, we silenced their expression using short hairpin RNAs. 237 We produced lentiviral particles containing shRNA that recognize PUM1, PUM2 and a Knockdown of PUM1 and PUM2 in hESCs affects cardiomyogenesis. 259 Considering the effects of Pumilio silencing in pluripotency factors, we also 260 evaluated their influence in cardiomyogenesis. After 48h of hESC transduction, cardiac 261 differentiation was induced. The transduction did affect neither the morphology of cells 262 nor the formation of EBs (D1 and D4) ( Figure 3A ). From the 9 th day, silenced EBs, 263 visually, presented some morphological differences with respect to their size compared 264 to the control cells ( Figure 3A ), though this difference was not statistically significant 265 ( Figure 3B ). In all conditions, the EBs contract spontaneously (Supplementary Video 266 1).
267
Analysis comparing shSc with shPUM knockdown conditions (shPUM1, 268 shPUM2 and shPUM1-2) showed that cells transduced with shPUM2 and shPUM1-2 269 increase the number of eGFP+ cells at D9 compared to cells transduced with shSc, but 270 not at D15 ( Figure 3C ). Regarding the efficiency of differentiation, on D15, the 9 271 percentage of cTnT+ cells not changed between the different treatments ( Figure 3C ).
272
These results demonstrated that when PUM was silenced, hESCs followed EBs cardiac 273 differentiation efficiently, with no statistically significant changes. 274 We performed a monolayer cardiomyogenic differentiation protocol, as 275 previously described (33) ( Figure 4A ). In this protocol we transfected hESCs with shSc Our results suggest that PUM1 and PUM2 may play a role in the cardiac 292 differentiation process. Thus, we investigated the expression profile of the targets 293 mRNA of PUM1 and PUM2 during cardiomyogenesis of hESCs using previously 294 published data (32). Briefly, mRNA population associated with polysomes in five time-295 points (days 0, 1, 4, 9 and 15) during the in vitro cardiac differentiation of hESCs were 296 isolated and sequenced (32). Using these data, we selected mRNA targets of PUM1 and 297 PUM2 and we evaluated the genes that increase after 1 and 4 days of cardiomyogeneses 298 ( Supplementary Table S2 ). Therefore, we investigated the impact of Pumilio proteins on stemness and 332 cardiomyogenesis by knocking down the two human paralogs, individually and in 333 combination. As discussed previously, PUM1 and PUM2 share most of their mRNA 334 targets (22,41), and a compensatory regulation mechanism has been observed when one 335 of these genes is silenced by increasing the expression of the other (43). We evaluated 336 the levels of PUM1 and PUM2 mRNAs after silencing these genes individually, and we 11 337 did not observe this compensation, at least at the mRNA level. We hypothesized that 338 due to their high similarity, the shRNA used to knockdown one transcript impacted the 339 stability of the other transcript, at least in this cell type. 340 We observed that the PUM1 and PUM2 silencing altered the mRNA levels of 341 two genes associated with the pluripotency phenotype, OCT4 and NANOG. In both 342 cases, the expression was significantly reduced in silenced cells in relation to the 343 control, suggesting that PUM proteins may be involved in the maintenance of hESC 344 pluripotency. These results corroborate with other studies that strongly suggest that PUF 345 proteins may mediate a widespread and ancient mechanism for repressing the 346 differentiation and maintaining the self-renewal of stem cells (10,15,44-47).
347
As Pumilio proteins seem to regulate the stemness phenotype, we examined the 348 effect of their silencing on hESC induced to two different protocols of in vitro 349 cardiomyogenesis. In EBs protocol, hESC silenced for PUM1 and/or PUM2 showed an 350 increase in the percentage of cTnT + cells, despite it was not statistically significant. that PUM1-2 silenced hESC exhibited a larger cTnT staining area than control cells. 356 These changes indicated that the reduction of PUM1 and PUM2, even over a short 357 period, can increase the number of cardiomyocytes generated from in vitro cardiac 358 differentiation protocols. The mechanism behind these effect needs to be investigated 359 but could be related to the decrease of pluripotent markers. to cardiomyogenic lineage are associated with polysomes, suggesting, as expected, that 371 these genes are expressed and translated. Besides that, among Pumilios targets mRNAs 372 we identified many transcription factors, which are key components of differentiation 373 processes. These results suggest that PUM1 and PUM2 could be regulators of 374 transcription factors expression during cardiomyogenesis. 375 Here we demonstrated that PUM1 and PUM2 are expressed throughout of hESC 376 in vitro cardiomyogenesis differentiation. Moreover, when both genes were knocked 377 down, we observed a reduction in pluripotency transcription factors expression and an 378 increase in cardiac differentiation efficiency. Through analysis of previous published 379 RNAseq data, we could identify many PUM targets mRNA modulated during 380 cardiomyogenesis. Despite that, the mechanism of these proteins in cardiac lineage 381 commitment still needs to be elucidated. 
